Structural models of human apolipoprotein A-I: a critical analysis and review

被引:216
作者
Brouillette, CG
Anantharamaiah, GM
Engler, JA
Borhani, DW
机构
[1] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[4] BASF Biores Corp, Worcester, MA 01605 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2001年 / 1531卷 / 1-2期
基金
美国国家卫生研究院;
关键词
apolipoprotein A-I mutant; high density lipoprotein; exchangeable apolipoprotein; apolipoprotein E; apolipophorin III; molten globule; HDL model; lipid binding; protein folding;
D O I
10.1016/S1388-1981(01)00081-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human apolipoprotein (apo) A-I has been the subject of intense investigation because of its well-documented antiatherogenic properties. About 70% of the protein found in high density lipoprotein complexes is apo A-I, a molecule that contains a series of highly homologous amphiphatic alpha -helices. A number of significant experimental observations have allowed increasing sophisticated structural models for both the lipid-bound and the lipid-free forms of the apo A-I molecule to be tested critically. It seems clear, for example, that interactions between amphipathic domains in apo A-I may be crucial to understanding the dynamic nature of the molecule and the pathways by which the lipid-free molecule binds to lipid, both in a discoidal and a spherical particle. The state of the art of these structural studies is discussed and placed in context with current models and concepts of the physiological role of apo A-I and high-density lipoprotein in atherosclerosis and lipid metabolism. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:4 / 46
页数:43
相关论文
共 262 条
  • [61] Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia
    Dong, LM
    Parkin, S
    Trakhanov, SD
    Rupp, B
    Simmons, T
    Arnold, KS
    Newhouse, YM
    Innerarity, TL
    Weisgraber, KH
    [J]. NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 718 - 722
  • [62] Durbin DM, 1999, J LIPID RES, V40, P2293
  • [63] High-density lipoprotein subclasses and apolipoprotein A-I
    Duriez, P
    Fruchart, JC
    [J]. CLINICA CHIMICA ACTA, 1999, 286 (1-2) : 97 - 114
  • [64] Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
    Duverger, N
    Kruth, H
    Emmanuel, F
    Caillaud, JM
    Viglietta, C
    Castro, G
    Tailleux, A
    Fievet, C
    Fruchart, JC
    Houdebine, LM
    Denefle, P
    [J]. CIRCULATION, 1996, 94 (04) : 713 - 717
  • [65] EDELSTEIN C, 1980, J BIOL CHEM, V255, P5747
  • [66] Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis
    ElliottBryant, R
    Cathcart, ES
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (01): : 104 - 108
  • [67] MECHANISMS FOR THE MODULATION OF MEMBRANE BILAYER PROPERTIES BY AMPHIPATHIC HELICAL PEPTIDES
    EPAND, RM
    SHAI, YC
    SEGREST, JP
    ANANTHARAMAIAH, GM
    [J]. BIOPOLYMERS, 1995, 37 (05) : 319 - 338
  • [68] HDL AND APOLIPOPROTEIN-A-I PROTECT ERYTHROCYTES AGAINST THE GENERATION OF PROCOAGULANT ACTIVITY
    EPAND, RM
    STAFFORD, A
    LEON, B
    LOCK, PE
    TYTLER, EM
    SEGREST, JP
    ANANTHARAMAIAH, GM
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (11): : 1775 - 1783
  • [69] Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module
    Fass, D
    Blacklow, S
    Kim, PS
    Berger, JM
    [J]. NATURE, 1997, 388 (6643) : 691 - 693
  • [70] FIELDING CJ, 1995, J LIPID RES, V36, P211